articles about mycoplasma
Ceva receives EU marketing authorization granted by the EU Commission for Cirbloc® M Hyo, a new Ready To Use vaccine to protect pigs against PCV2 and Mycoplasma hyopneumoniae
The new vaccine is based on the PCV2d genotype, the most circulating one in the field and on the Mycoplasma hyopneumoniae (M. hyo) strain BA 2940.
Summary of the 27th IPVS and 15th ESPHM-ECPHM: sanitation, immunology, vaccines
In this second installment, Antonio Palomo summarizes the papers and posters on health, immunology, and vaccines presented at the latest edition of the IPVS and ESPHM-ECPHM in Leipzig.
55th AASV Annual Meeting summary: Health
Antonio Palomo summarizes the presentations on swine health from the recent edition of the AASV that took place in Nashville (Tennessee).
Productive and economic impact of pig lung lesions detected at slaughter
Detection of lung lesions in slaughtered pigs also allows estimation of economic losses.
Dysbiosis of gut microbiota and intestinal barrier dysfunction in pigs with pulmonary inflammation induced by Mycoplasma hyorhinis infection
The impact of discontinuing perinatal antibiotic treatments in piglets
Side effects of perinatal medications on the microbiota can be detrimental to animal health.
The effect of gilt flow management during acclimation on Mycoplasma hyopneumoniae detection
Mycoplasma hyopneumoniae vaccines
This article presents the main characteristics of the vaccines that can be found on the market.
PCR assay as a diagnostic tool (2/2): Uses and interpretation of the results
How to interpret a negative or positive PCR result with specific examples of what could be happening.
Boehringer Ingelheim's TwistPak® mixing platform for swine vaccines brings convenience and flexibility
University of Minnesota swine professors receive awards at CVM Research Day
Dr. Maria Pieters and Dr. Noelle Noyes receive awards at the Points of Pride Research Day of the UMN College of Veterinary Medicine.
How does swine influenza virus facilitate secondary bacterial complications?
The influenza virus promotes colonization by secondary bacterial agents in the lung, facilitating their passage into the bloodstream.
Laboratory diagnostics: Mycoplasma hyopneumoniae
What laboratory diagnostic methods can I use to diagnose M. hyo? Which one should I choose according to the situation? How do I interpret the results?
Ceva receives positive opinion from EMA for Circovac® + Hyogen® Ready to Mix: DUO™ swine vaccines
Zoetis launches CircoMax® Myco to deliver broader coverage against PCV2
Unique PCV2 and M. hyopneumoniae ready-to-use, single-dose combination vaccine on the market.